TY - JOUR T1 - Up-Regulation of Glutathione <em>S</em>-Transferase Activity in Enterocytes of Young Children JF - Drug Metabolism and Disposition JO - Drug Metab Dispos SP - 1466 LP - 1469 VL - 27 IS - 12 AU - John P. Gibbs AU - Chris A. Liacouras AU - Robert N. Baldassano AU - John T. Slattery Y1 - 1999/12/01 UR - http://dmd.aspetjournals.org/content/27/12/1466.abstract N2 - The relationship between age and busulfan apparent oral clearance (Cl/F) expressed relative to adjusted ideal body weight and body surface area (bsa) was evaluated in 135 children aged 0 to 16 years undergoing hematopoietic stem cell transplantation for various disorders. Busulfan plasma levels were measured by gas chromatography-mass spectrometry after the first daily dose of the 4-day dosing regimen. Cl/F expressed relative to adjusted ideal body weight (ml/min/kg) and bsa (ml/min/m2) was lower in 9- to 16-year-old (y.o.) compared with 0- to 4-y.o. children (49 and 30%; p &lt; .001). We hypothesized that the greater busulfan Cl/F observed in young children was in part due to enhanced (first-pass intestinal) metabolism. Busulfan conjugation rate was compared in incubations with human small intestinal biopsy specimens from healthy young (1- to 3-y.o.) and older (9- to 17-y.o.) children. Villin content in biopsy specimens was determined by Western blot and busulfan conjugation rate was expressed relative to villin content to control for differences in epithelial cell content in pinch biopsies. Intestinal biopsy specimens from young children had a 77% higher busulfan conjugation rate (p = .037) compared with older children. We have previously shown that glutathione-S-transferase (GST) A1–1 is the major isoform involved in busulfan conjugation, and that this enzyme is expressed uniformly along the length of adult small intestine. Thus, the greater busulfan conjugation activity in intestinal biopsies of the young children was most likely due to enhanced GSTA1–1 expression. We conclude that age dependence in busulfan Cl/F appears to result at least in part from enhanced intestinal GSTA1–1 expression in young children. The American Society for Pharmacology and Experimental Therapeutics ER -